Patents Assigned to The United States of America, as Represented by the Secretary, Department of Health and Human Services Food and Drug Administration
Abstract: The present is directed to compositions comprising regulatory T cell epitopes, wherein said epitopes comprise a polypeptide comprising at least a portion of SEQ NOS: 1-14, fragments and/or variants thereof, as well as methods of producing and using the same.
Type:
Grant
Filed:
October 5, 2018
Date of Patent:
September 13, 2022
Assignees:
EpiVax Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services Food and Drug Administration